Indivior plc (GB:INDV) has released an update.
Indivior PLC, a global pharmaceutical company specializing in treatments for substance use disorders and serious mental illnesses, announced its participation in two major investor conferences. The company’s management team will engage in one-on-one and group meetings at the Craig-Hallum Institutional Investor Conference on May 29th and a presentation by CEO Mark Crossley at the Jefferies Global Healthcare Conference on June 5th. These events are part of Indivior’s efforts to connect with investors and share developments related to their product pipeline and global initiatives.
For further insights into GB:INDV stock, check out TipRanks’ Stock Analysis page.
